| Previous Section | Index | Home Page |
Health Authority Funding (West Midlands)
Mr. Jenkins: To ask the Secretary of State for Health if he will list for each health authority in (a) the West Midlands and (b) shire counties (i) the total funding allocation for health services and (ii) the funding per capita for (1) 1996-97 and (2) 1997-98. [68332]
Mr. Denham: The information requested is shown in the table.
For the per capita figures crude populations have been used. No account has been taken of the differences in age or other factors which influence the allocations which have been made.
2 Feb 1999 : Column: 525
2 Feb 1999 : Column: 527
Notes:
1. Final cash limit is the sum of the initial cash limit plus all in year adjustments. Cash limit adjustments in respect of the temporary loan of cash limits to other authorities have been excluded.
2. Health authorities are not co-terminous with local authorities. The list of health authorities under "other" is intended to broadly equate to shire counties. It excludes health authorities whose areas mainly relate to metropolitan councils and London boroughs.
3. The 1996-97 population figures used are mid-year population projections based on 1993 estimates. The 1997-98 population figures used are mid-year population projections based on 1995 estimates.
2 Feb 1999 : Column: 529
2 Feb 1999 : Column: 529
Mr. David Taylor:
To ask the Secretary of State for Health which health authorities fund the use of stereotactic radiosurgery; and what constraints are imposed by him in respect of the funding of clinical procedures capable of being classified as in the realms of research. [67709]
Mr. Hutton:
Stereotactic radiosurgery is available in eight of some fifty radiotherapy centres in the United Kingdom. The technique is well established for certain
2 Feb 1999 : Column: 530
well-defined conditions which would be expected to occur in patients spread fairly evenly across all health authorities. Health authorities make resource allocation decisions according to local priorities.
We encourage National Health Service bodies to undertake experimental treatments only within an evaluative framework. Any decisions to fund experimental treatments as research will be influenced by their importance to the health service and assessments on the value of the research.
2 Feb 1999 : Column: 531
| Next Section | Index | Home Page |